BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 34305945)

  • 1.
    Clegg J; Soldaini E; McLoughlin RM; Rittenhouse S; Bagnoli F; Phogat S
    Front Immunol; 2021; 12():705360. PubMed ID: 34305945
    [No Abstract]   [Full Text] [Related]  

  • 2. Design of
    Soltan MA; Magdy D; Solyman SM; Hanora A
    OMICS; 2020 Apr; 24(4):195-204. PubMed ID: 32286190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Staphylococcal Antigen-F (r-ScaF), a novel vaccine candidate against methicillin resistant Staphylococcus aureus infection: Potency and efficacy studies.
    Majelan PA; Mahdavi M; Yazdi MH; Salimi E; Pourmand MR
    Microb Pathog; 2019 Feb; 127():159-165. PubMed ID: 30521844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination with a live-attenuated small-colony variant improves the humoral and cell-mediated responses against Staphylococcus aureus.
    Côté-Gravel J; Brouillette E; Malouin F
    PLoS One; 2019; 14(12):e0227109. PubMed ID: 31881064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evasion of Immunological Memory by
    Teymournejad O; Montgomery CP
    Front Immunol; 2021; 12():633672. PubMed ID: 33692805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against Staphylococcus aureus Colonization and Infection by B- and T-Cell-Mediated Mechanisms.
    Zhang F; Ledue O; Jun M; Goulart C; Malley R; Lu YJ
    mBio; 2018 Oct; 9(5):. PubMed ID: 30327437
    [No Abstract]   [Full Text] [Related]  

  • 7. Master mechanisms of Staphylococcus aureus: consider its excellent protective mechanisms hindering vaccine development!
    Zhang X; Marichannegowda MH; Rakesh KP; Qin HL
    Microbiol Res; 2018; 212-213():59-66. PubMed ID: 29853168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of Staphylococcus aureus infections by glycoprotein vaccines synthesized in Escherichia coli.
    Wacker M; Wang L; Kowarik M; Dowd M; Lipowsky G; Faridmoayer A; Shields K; Park S; Alaimo C; Kelley KA; Braun M; Quebatte J; Gambillara V; Carranza P; Steffen M; Lee JC
    J Infect Dis; 2014 May; 209(10):1551-61. PubMed ID: 24308931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial extracellular vesicle-coated multi-antigenic nanovaccines protect against drug-resistant
    Chen G; Bai Y; Li Z; Wang F; Fan X; Zhou X
    Theranostics; 2020; 10(16):7131-7149. PubMed ID: 32641983
    [No Abstract]   [Full Text] [Related]  

  • 10. Staphylococcus aureus vaccine strategy: Promise and challenges.
    Chand U; Priyambada P; Kushawaha PK
    Microbiol Res; 2023 Jun; 271():127362. PubMed ID: 36958134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of genetically inactivated alpha toxin for protection in multiple mouse models of Staphylococcus aureus infection.
    Brady RA; Mocca CP; Prabhakara R; Plaut RD; Shirtliff ME; Merkel TJ; Burns DL
    PLoS One; 2013; 8(4):e63040. PubMed ID: 23658662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and evaluation of vaccine against Staphylococcus aureus recovered from naturally occurring mastitis in she-camels.
    Aqib AI; Anjum AA; Ijaz M; Hussain R; Ahmed R; Farooqi SH; Aslam HB; Hussain K; Mehmood K; Zhang H
    Microb Pathog; 2018 Apr; 117():341-347. PubMed ID: 29510207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying protective antigens of Staphylococcus aureus, a pathogen that suppresses host immune responses.
    Kim HK; Kim HY; Schneewind O; Missiakas D
    FASEB J; 2011 Oct; 25(10):3605-12. PubMed ID: 21753082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomics-based identification of anchorless cell wall proteins as vaccine candidates against Staphylococcus aureus.
    Glowalla E; Tosetti B; Krönke M; Krut O
    Infect Immun; 2009 Jul; 77(7):2719-29. PubMed ID: 19364833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response and functional role of antibodies raised in heifers against a Staphylococcus aureus CP5 lysate and recombinant antigens vaccine formulated with Iscom Matrix adjuvant.
    Camussone CM; Pujato N; Renna MS; Veaute CM; Morein B; Marcipar IS; Calvinho LF
    Vet Immunol Immunopathol; 2014 Dec; 162(3-4):96-107. PubMed ID: 25454469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a future for a Staphylococcus aureus vaccine?
    Proctor RA
    Vaccine; 2012 Apr; 30(19):2921-7. PubMed ID: 22115633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Considering the 'Alternatives' for Next-Generation Anti-Staphylococcus aureus Vaccine Development.
    O'Brien EC; McLoughlin RM
    Trends Mol Med; 2019 Mar; 25(3):171-184. PubMed ID: 30713007
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Wójcik-Bojek U; Różalska B; Sadowska B
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.
    Li X; Wang X; Thompson CD; Park S; Park WB; Lee JC
    mBio; 2016 Feb; 7(1):e02232-15. PubMed ID: 26838725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a vaccine against Staphylococcus aureus.
    Spellberg B; Daum R
    Semin Immunopathol; 2012 Mar; 34(2):335-48. PubMed ID: 22080194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.